Teva Pharmaceutical Industries (NYSE:TEVA) reported Q4 17 earnings this Morning, coming in at $0.93 per share, beating Wall Street’s estimates of $0.76 per Share. Revenue for the quarter came in at $5.46 billion beating analyst estimates of $5.29 billion
Dividend History for Teva Pharmaceutical Industries (NYSE:TEVA)
- On 11/2/2017 announced a quarterly dividend of $0.09 2.74% with an ex dividend date of 11/27/2017 which will be payable on 11/28/2017.
- On 8/7/2017 announced a quarterly dividend of $0.09 1.83% with an ex dividend date of 8/25/2017 which will be payable on 8/29/2017.
- On 5/11/2017 announced a quarterly dividend of $0.34 4.28% with an ex dividend date of 6/1/2017 which will be payable on 6/5/2017.
- On 2/13/2017 announced a quarterly dividend of $0.34 3.7% with an ex dividend date of 2/28/2017 which will be payable on 3/2/2017.
- On 11/15/2016 announced a quarterly dividend of $0.34 with an ex dividend date of 12/1/2016 which will be payable on 12/5/2016.
- On 8/4/2016 announced a quarterly dividend of $0.34 with an ex dividend date of 8/18/2016 which will be payable on 8/22/2016.
- On 5/9/2016 announced a quarterly dividend of $0.34 with an ex dividend date of 5/20/2016 which will be payable on 5/24/2016.
Recent Trading for Teva Pharmaceutical Industries (NYSE:TEVA) Shares of Teva Pharmaceutical Industries closed the previous trading session at 18.70 down -2.15 10.31% with 18.719999313354492 shares trading hands.